Drug: Efavirenz Injury: Exposure during pregnancy Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126703491 | Efavirenz | Exposure during pregnancy | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160822 | US |
126704131 | Efavirenz | Exposure during pregnancy | VIIV | 0.00 | F | 0 | 20160822 | US |
126746572 | EFAVIRENZ | Exposure during pregnancy | GILEAD | 29.00 YR | F | 78 KG | 20160929 | ZA |
126764202 | Efavirenz | Exposure during pregnancy | VIIV | 29.00 YR | F | 78 KG | 20160930 | ZA |
126764652 | Efavirenz | Exposure during pregnancy | GLAXOSMITHKLINE | 29.00 YR | F | 78 KG | 20160930 | ZA |
126785981 | EFAVIRENZ | Exposure during pregnancy | GILEAD | 31.00 YR | F | 0 | 20160823 | ZA |
127028551 | Efavirenz | Exposure during pregnancy | VIIV | 31.00 YR | F | 0 | 20160831 | ZA |
127030391 | Efavirenz | Exposure during pregnancy | GLAXOSMITHKLINE | 31.00 YR | F | 0 | 20160831 | ZA |
Total Records: 8 Number of Pages: 1